Login

Switch On Your HIV Smarts.

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

, by Liz Highleyman

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

, by Liz Highleyman

People taking only two drugs, dolutegravir and rilpivirine, maintained viral suppression in participants of the SWORD-1 an SWORD-2 studies. Read More

Sci-fi ways to treat HIV: Implants, monoclonal antibodies & more

Sci-fi ways to treat HIV: Implants, monoclonal antibodies & more

, by Emily Newman

Researchers are working on new treatment options that will make treating HIV easier than ever before. Read More

New research shows abnormal immune activation even in very early HIV infection

New research shows abnormal immune activation even in very early HIV infection

, by Emily Newman

Findings may help explain why early ART may improve, but fail to fully restore, health and life expectancies of people living with HIV on therapy. Read More

Repealing Obamacare will have “devastating” consequences for millions—and many who are living with HIV

Repealing Obamacare will have “devastating” consequences for millions—and many who are living with HIV

, by Emily Newman

Will the incoming administration be able to repeal the Affordable Care Act? And if so, how might if affect people living with HIV? Read More